CANC vs. BBC ETF Comparison
Comparison of Tema Oncology ETF (CANC) to Virtus LifeSci Biotech Clinical Trials ETF (BBC)
CANC
Tema Oncology ETF
CANC Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$27.01
Average Daily Volume
21,142
Number of Holdings
*
8
* may have additional holdings in another (foreign) market
BBC
Virtus LifeSci Biotech Clinical Trials ETF
BBC Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Grade (RS Rating)
Last Trade
$24.75
Average Daily Volume
3,301
Number of Holdings
*
102
* may have additional holdings in another (foreign) market
Performance
| Period | CANC | BBC |
|---|---|---|
| 30 Days | -2.17% | -11.45% |
| 60 Days | -1.71% | -11.48% |
| 90 Days | -0.07% | -9.60% |
| 12 Months | 5.28% |
1 Overlapping Holdings
| Symbol | Grade | Weight in CANC | Weight in BBC | Overlap | |
|---|---|---|---|---|---|
| RVMD | D | 2.85% | 0.85% | 0.85% |
CANC Underweight 101 Positions Relative to BBC
| Symbol | Grade | Weight | |
|---|---|---|---|
| LBPH | B | -1.47% | |
| NRIX | C | -1.07% | |
| MORF | C | -1.05% | |
| IRON | C | -1.04% | |
| CELC | B | -0.98% | |
| SVRA | C | -0.98% | |
| ARQT | B | -0.95% | |
| PCVX | B | -0.95% | |
| CYTK | D | -0.95% | |
| EWTX | B | -0.94% | |
| ANAB | B | -0.94% | |
| DYN | B | -0.93% | |
| ABUS | B | -0.92% | |
| ERAS | C | -0.92% | |
| PTGX | B | -0.92% | |
| IMVT | D | -0.91% | |
| CLDX | F | -0.91% | |
| ELVN | B | -0.9% | |
| ORIC | D | -0.9% | |
| NUVB | C | -0.9% | |
| ACLX | C | -0.9% | |
| DNLI | C | -0.89% | |
| VKTX | D | -0.89% | |
| SNDX | C | -0.89% | |
| HLVX | C | -0.88% | |
| MLYS | C | -0.88% | |
| CRNX | D | -0.87% | |
| ARWR | C | -0.87% | |
| XENE | F | -0.87% | |
| KURA | D | -0.86% | |
| BEAM | D | -0.86% | |
| COGT | C | -0.86% | |
| RNA | C | -0.86% | |
| VRDN | F | -0.86% | |
| VERA | C | -0.86% | |
| PHVS | F | -0.86% | |
| PRTA | F | -0.86% | |
| JANX | D | -0.84% | |
| SLN | D | -0.84% | |
| NUVL | C | -0.84% | |
| IMTX | C | -0.84% | |
| BLTE | C | -0.84% | |
| VERV | F | -0.84% | |
| MRUS | C | -0.84% | |
| MGNX | F | -0.83% | |
| CMPS | D | -0.83% | |
| ARVN | F | -0.83% | |
| ITOS | D | -0.83% | |
| LQDA | C | -0.82% | |
| AKRO | C | -0.82% | |
| ALEC | F | -0.82% | |
| RCKT | F | -0.81% | |
| PLRX | F | -0.81% | |
| NTLA | F | -0.81% | |
| CGON | D | -0.81% | |
| PGEN | C | -0.8% | |
| KYMR | D | -0.8% | |
| XNCR | F | -0.8% | |
| FDMT | D | -0.79% | |
| TYRA | C | -0.79% | |
| IDYA | F | -0.79% | |
| REPL | C | -0.79% | |
| OLMA | D | -0.79% | |
| TERN | C | -0.79% | |
| CNTA | D | -0.79% | |
| RCUS | F | -0.78% | |
| VIR | F | -0.78% | |
| EDIT | F | -0.78% | |
| SMMT | C | -0.78% | |
| KROS | F | -0.78% | |
| APLT | C | -0.77% | |
| WVE | C | -0.76% | |
| SRRK | F | -0.76% | |
| RGNX | F | -0.76% | |
| IGMS | F | -0.75% | |
| ABCL | F | -0.75% | |
| ALLO | F | -0.75% | |
| RLAY | F | -0.74% | |
| ETNB | F | -0.74% | |
| BCYC | C | -0.74% | |
| FULC | F | -0.73% | |
| ANNX | D | -0.73% | |
| RXRX | F | -0.72% | |
| CVAC | F | -0.72% | |
| LRMR | D | -0.72% | |
| CGEM | D | -0.71% | |
| AUTL | F | -0.71% | |
| IMNM | F | -0.7% | |
| QURE | F | -0.69% | |
| STOK | D | -0.67% | |
| SANA | F | -0.67% | |
| ARCT | F | -0.64% | |
| PRME | F | -0.62% | |
| ALXO | F | -0.61% | |
| CABA | F | -0.55% | |
| LYEL | F | -0.54% | |
| SAVA | F | -0.5% | |
| TSHA | F | -0.47% | |
| ZNTL | F | -0.34% | |
| SCLX | C | -0.29% | |
| AVTE | F | -0.06% |
CANC: Top Represented Industries & Keywords
BBC: Top Represented Industries & Keywords
Compare ETFs
